[1]
Elyasi, S. et al. 2018. Evaluation of Correlation Between Serum Level of Dihydropyrimidine Dehydrogenase Enzyme and Capecitabine Induced Adverse Reaction. Reports of Radiotherapy and Oncology. 4, 1 (Aug. 2018), 1–6.